Neil Jasey, MD
Physical Medicine & Rehabilitation · New York, NYNPI 1659538551
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,001 of the $28,680 with a category attached, or 66.3%. Merz Pharmaceuticals, LLC accounts for 89.5% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $12,765 and has fallen 97.6% since, to $310 in 2025. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $283.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz Pharmaceuticals, LLC$26K
- Flowonix Medical Incorporated$2K
- AbbVie$501
- Merz North America, Inc.$194
- Azurity Pharmaceuticals, Inc.$98
- Coloplast$60
- plus $408 from 21 others
Across 20 payments — averaging $273.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merz North America, Inc.$5K
- Merz Pharmaceuticals, LLC$827
What the payments were for
- Consulting fees$19,00166%
- Speaking & faculty fees$6,66023%
- Travel & lodging$9533%
- Food & beverage$1,8276%
- Education$2391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz Pharmaceuticals, LLC | 31 | $25,660 |
| Flowonix Medical Incorporated | 1 | $1,759 |
| AbbVie(2 entities) | 29 | $501 |
| Merz North America, Inc. | 4 | $194 |
| Azurity Pharmaceuticals, Inc. | 6 | $98 |
| Coloplast | 3 | $60 |
| Amgen | 2 | $35 |
| Vertex | 2 | $29 |
| Bioventus LLC | 1 | $29 |
| AstraZeneca | 2 | $27 |
| Pacira Therapeutics, Inc. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 2 | $27 |
| Collegium Pharmaceutical, Inc. | 2 | $25 |
| Abbott | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Argenx US, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Biogen | 1 | $14 |
| Tersera Therapeutics LLC | 1 | $14 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$25,264
- Prometra II$1,759
How this compares
$28,680 in reported general payments places this provider in the 95th percentile of 872 physical medicine & rehabilitation providers in New York.
See all physical medicine & rehabilitation providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $8,805 |
| AmantadineAmantadine Hcl | 26 | $1,090 |
| Armodafinil | 12 | $722 |
| Gabapentin | 58 | $628 |
| Baclofen | 32 | $537 |
| Quetiapine Fumarate | 21 | $394 |
| Duloxetine Hcl | 19 | $357 |
| Trazodone Hcl | 80 | $335 |
| Escitalopram Oxalate | 58 | $333 |
| Nortriptyline Hcl | 19 | $261 |
| Venlafaxine Hcl | 19 | $254 |
| Lamotrigine | 32 | $233 |
| Pantoprazole Sodium | 27 | $192 |
| Memantine Hcl | 13 | $167 |
| Alprazolam | 16 | $164 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in New York
- Heidi FuscoNew York$153K
- Michael OdellNew York$67K
- Craig AntellNew York$65K
- Michael StubblefieldNew York$53K
- Heakyung KimNew York$53K
- Russell SilverNew York$34K
- Julia IafrateNew York$32K
- Christian CustodioNew York$19K
- Karan JoharNew York$14K
- Samantha ErosaNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.